130 related articles for article (PubMed ID: 23618899)
21. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
22. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
[TBL] [Abstract][Full Text] [Related]
23. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
24. Early loss of Fhit in the respiratory tract of rodents exposed to environmental cigarette smoke.
D'Agostini F; Izzotti A; Balansky R; Zanesi N; Croce CM; De Flora S
Cancer Res; 2006 Apr; 66(7):3936-41. PubMed ID: 16585223
[TBL] [Abstract][Full Text] [Related]
25. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
26. Oncosuppressor proteins of fragile sites are reduced in cervical cancer.
Giarnieri E; Zanesi N; Bottoni A; Alderisio M; Lukic A; Vecchione A; Ziparo V; Croce CM; Mancini R
Cancer Lett; 2010 Mar; 289(1):40-5. PubMed ID: 19700237
[TBL] [Abstract][Full Text] [Related]
27. Roles of oxidative stress and the ERK1/2, PTEN and p70S6K signaling pathways in arsenite-induced autophagy.
Huang YC; Yu HS; Chai CY
Toxicol Lett; 2015 Dec; 239(3):172-81. PubMed ID: 26432159
[TBL] [Abstract][Full Text] [Related]
28. Sodium arsenite induces cyclooxygenase-2 expression in human uroepithelial cells through MAPK pathway activation and reactive oxygen species induction.
Wang H; Xi S; Xu Y; Wang F; Zheng Y; Li B; Li X; Zheng Q; Sun G
Toxicol In Vitro; 2013 Apr; 27(3):1043-8. PubMed ID: 23376440
[TBL] [Abstract][Full Text] [Related]
29. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
30. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
Karras JR; Schrock MS; Batar B; Huebner K
Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
[TBL] [Abstract][Full Text] [Related]
31. Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells.
Chai CY; Huang YC; Hung WC; Kang WY; Chen WT
Mutagenesis; 2007 Nov; 22(6):403-8. PubMed ID: 17906315
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the role of Fhit in suppression of DNA damage.
Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
34. Expression of STAT3 and Bcl-6 oncoprotein in sodium arsenite-treated SV-40 immortalized human uroepithelial cells.
Huang YC; Hung WC; Kang WY; Chen WT; Chai CY
Toxicol Lett; 2007 Aug; 173(1):57-65. PubMed ID: 17689208
[TBL] [Abstract][Full Text] [Related]
35. [Fragile histidine triad expression in rhabdomyosarcoma].
Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
[TBL] [Abstract][Full Text] [Related]
36. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the fragile histidine triad (FHIT) gene in inflammatory bowel disease.
Wierzbicki PM; Adrych K; Kartanowicz D; Wypych J; Stanislawowski M; Zwolinska-Wcislo M; Celinski K; Skrodzka D; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():57-62. PubMed ID: 20083852
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
[TBL] [Abstract][Full Text] [Related]
40. Aberrant β-catenin expression in urothelial carcinomas in blackfoot disease-endemic areas.
Chen YT; Wu CC; Liu XP; Chai CY
Kaohsiung J Med Sci; 2017 Jan; 33(1):11-16. PubMed ID: 28088268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
